Morgan Stanley Uruguay Ltda. recently announced the acquisition of new stake in Natura &Co Holding S.A. ADR (NYSE:NTCO). The institutional investor has increased its shareholding in the Consumer Defensive company by 345.96% to 1.56 million shares with purchase of 1.21 million shares. This fresh investment now brings its stake to 0.22% valued currently at $10.37 million. In addition, Parametric Portfolio Associates L raised its holdings by 18636.0 to 1.54 million shares. And Optiver US LLC has lifted its position by 110.07% or 0.57 million shares – to 1.09 million shares.
With over 0.5 million Natura &Co Holding S.A. ADR (NTCO) shares trading Friday and a closing price of $6.71 on the day, the dollar volume was approximately $3.33 million. The shares have shown a negative half year performance of -8.33% and its price on 12/22/23 lost nearly -0.89%. Currently, there are 690.31M common shares owned by the public and among those 689.71M shares have been available to trade.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The top 3 mutual fund holders in Natura &Co Holding S.A. ADR are Dolmen Green Effects, Old Westbury Small & Mid Cap Stra, and Ascese Fundo de Investimentos em. Dolmen Green Effects owns 0.74 million shares of the company’s stock, all valued at over $4.95 million. The company bought an additional 0.15 million shares recently to bring their total holdings to about 0.11% of the shares outstanding. Ascese Fundo de Investimentos em now owns shares totaling to 0.05% of the shares outstanding.
Shares of Natura &Co Holding S.A. ADR (NYSE: NTCO) opened at $6.67, down -$0.1 from a prior closing price of $6.77. However, the script later moved the day high at 6.72, down -0.89%. The company’s stock has a 5-day price change of 5.01% and 8.23% over the past three months. NTCO shares are trading 54.97% year to date (YTD), with the 12-month market performance up to 56.78% higher. It has a 12-month low price of $3.72 and touched a high of $7.68 over the same period. NTCO has an average intraday trading volume of 672.82K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -0.53%, 12.05%, and 12.96% respectively.
Institutional ownership of Natura &Co Holding S.A. ADR (NYSE: NTCO) shares accounts for 4.22% of the company’s 690.31M shares outstanding. Mutual fund holders own 0.42%, while other institutional holders and individual stakeholders account for 3.78% and — respectively.
It has a market capitalization of $4.63B and a beta (3y monthly) value of 2.03. The earnings-per-share (ttm) stands at -$0.71. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.49% over the week and 3.19% over the month.
Analysts forecast that Natura &Co Holding S.A. ADR (NTCO) will achieve an EPS of $0.07 for the current quarter, $0.03 for the next quarter and $0.3 for 2024. The lowest estimate earnings-per-share for the quarter is $0.05 while analysts give the company a high EPS estimate of $0.1. Comparatively, EPS for the current quarter was -$0.24 a year ago. Earnings per share for the fiscal year are expected to increase by 74.68%, and 232.85% over the next financial year.
If you are looking to buy this stock, then you may note that the average analyst recommendation by 10 brokerage firm advisors rate Natura &Co Holding S.A. ADR (NTCO) as a “Moderate Buy” at a consensus score of 2.00. Specifically, 5 Wall Street analysts polled rate the stock as a buy, while 5 of the 10 advise that investors “hold,” and 0 rated it as a “Sell.”
Looking at the support for the NTCO, a number of firms have released research notes about the stock. JP Morgan stated their Overweight rating for the stock in a research note on October 19, 2022, with the firm’s price target at $7-$8.
